clindamycin hydrochloride

Generic: clindamycin hydrochloride

Labeler: redpharm drug
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clindamycin hydrochloride
Generic Name clindamycin hydrochloride
Labeler redpharm drug
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

clindamycin hydrochloride 300 mg/1

Manufacturer
Redpharm Drug

Identifiers & Regulatory

Product NDC 67296-2149
Product ID 67296-2149_4637f034-6779-2599-e063-6394a90a7290
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216957
Listing Expiration 2026-12-31
Marketing Start 2023-03-10

Pharmacologic Class

Classes
decreased sebaceous gland activity [pe] lincosamide antibacterial [epc] lincosamides [cs] neuromuscular blockade [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 672962149
Hyphenated Format 67296-2149

Supplemental Identifiers

RxCUI
284215
UPC
0368462142011
UNII
T20OQ1YN1W

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clindamycin hydrochloride (source: ndc)
Generic Name clindamycin hydrochloride (source: ndc)
Application Number ANDA216957 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 21 CAPSULE in 1 BOTTLE (67296-2149-1)
  • 28 CAPSULE in 1 BOTTLE (67296-2149-2)
  • 30 CAPSULE in 1 BOTTLE (67296-2149-3)
  • 40 CAPSULE in 1 BOTTLE (67296-2149-4)
source: ndc

Packages (4)

Ingredients (1)

clindamycin hydrochloride (300 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4637f034-6779-2599-e063-6394a90a7290", "openfda": {"upc": ["0368462142011"], "unii": ["T20OQ1YN1W"], "rxcui": ["284215"], "spl_set_id": ["3256c93b-f26c-aeb9-e063-6394a90ae9c2"], "manufacturer_name": ["Redpharm Drug"]}, "finished": true, "packaging": [{"sample": false, "description": "21 CAPSULE in 1 BOTTLE (67296-2149-1)", "package_ndc": "67296-2149-1", "marketing_start_date": "20230310"}, {"sample": false, "description": "28 CAPSULE in 1 BOTTLE (67296-2149-2)", "package_ndc": "67296-2149-2", "marketing_start_date": "20230310"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (67296-2149-3)", "package_ndc": "67296-2149-3", "marketing_start_date": "20230310"}, {"sample": false, "description": "40 CAPSULE in 1 BOTTLE (67296-2149-4)", "package_ndc": "67296-2149-4", "marketing_start_date": "20230310"}], "brand_name": "Clindamycin Hydrochloride", "product_id": "67296-2149_4637f034-6779-2599-e063-6394a90a7290", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Lincosamide Antibacterial [EPC]", "Lincosamides [CS]", "Neuromuscular Blockade [PE]"], "product_ndc": "67296-2149", "generic_name": "Clindamycin Hydrochloride", "labeler_name": "Redpharm Drug", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clindamycin Hydrochloride", "active_ingredients": [{"name": "CLINDAMYCIN HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA216957", "marketing_category": "ANDA", "marketing_start_date": "20230310", "listing_expiration_date": "20261231"}